Form 4: JFrog CTO Sells Shares Under Pre-Arranged 10b5-1 Plan

JFrog's Chief Technology Officer and Director, Yoav Landman, sold 45,000 ordinary shares for over $3 million in December 2025 through a pre-arranged Rule 10b5-1 trading plan.

Summary

• Yoav Landman, the Chief Technology Officer and a Director of JFrog Ltd. (FROG), reported sales of ordinary shares.
• A total of 45,000 ordinary shares were sold on December 12, 2025, across three separate transactions.
• The sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Landman on September 1, 2025.
• The shares were sold at weighted average prices of $68.12, $69.16, and $69.72.
• Following these transactions, Mr. Landman beneficially owns 5,913,641 ordinary shares directly.

Sentiment

Score: 5

Explanation: The sales are part of a pre-arranged 10b5-1 plan, which is a common practice for executive liquidity and diversification, and does not inherently signal a change in company fundamentals or management's long-term view. Therefore, the sentiment is neutral.

Positives

• The sales were conducted under a Rule 10b5-1 trading plan, which provides transparency by indicating the decision to sell was made in advance and not based on immediate, non-public information.

Negatives

• The sale of a significant number of shares (45,000) by a key executive and director could be perceived negatively by some investors, potentially raising questions about management's confidence, despite the pre-arranged nature of the sales.

Risks

• NA

Future Outlook

NA

Industry Context

NA

Corporate Governance

Stakeholder Impact

• Shareholders: May view the sale of a significant number of shares by a key executive with some concern, though the 10b5-1 plan mitigates the implication of trading on inside information. The remaining beneficial ownership of over 5.9 million shares indicates continued significant alignment with shareholder interests.

Key Dates

Recommendation

The insider sale by the CTO was conducted under a pre-arranged 10b5-1 trading plan, indicating the decision to sell was made in advance and not based on immediate, non-public information. While insider selling can sometimes be viewed negatively, sales under a 10b5-1 plan are often for personal financial planning, diversification, or liquidity and do not necessarily reflect a negative outlook on the company's future performance. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide a strong signal for a change in investment thesis.

Keywords

JFrog, FROG, insider trading, Form 4, stock sale, CTO, director, 10b5-1 plan, equity transaction